RT Journal Article
SR Electronic
T1 Investigating childhood maltreatment as a modifier of genetic risk for cardiovascular disease in the UK Biobank
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.01.26.22269809
DO 10.1101/2022.01.26.22269809
A1 Urquijo, Helena
A1 Soares, Ana Gonçalves
A1 Fraser, Abigail
A1 Howe, Laura D
A1 Carter, Alice R
YR 2022
UL http://medrxiv.org/content/early/2022/02/01/2022.01.26.22269809.abstract
AB Cardiovascular disease (CVD) is influenced by genetic and environmental factors. Childhood maltreatment is associated with CVD and may modify genetic susceptibility to cardiovascular risk factors. We used genetic and phenotypic data from 100,833 White British UK Biobank participants (57% female; mean age = 55.9 years). We regressed nine cardiovascular risk factors/diseases (alcohol consumption, body mass index [BMI], low-density lipoprotein cholesterol, lifetime smoking behaviour, systolic blood pressure, atrial fibrillation, coronary heart disease, type 2 diabetes, and stroke) on their respective polygenic scores (PGS) and self-reported exposure to childhood maltreatment. Effect modification was tested on the additive and multiplicative scales by including a product term (PGS*maltreatment) in regression models.On the additive scale, childhood maltreatment accentuated the effect of genetic susceptibility to higher BMI. Individuals not exposed to childhood maltreatment had an increase in BMI of 0.12 SD (95% CI: 0.11, 0.13) per SD increase in BMI PGS, compared to 0.17 SD (95% CI: 0.14, 0.19) in those exposed to all types of childhood maltreatment. On the multiplicative scale, similar results were obtained for BMI though these did not withstand to Bonferroni correction. There was little evidence of effect modification by childhood maltreatment in relation to other outcomes, or of sex-specific effect modification.Our study suggests the effects of genetic susceptibility to a higher BMI may be moderately accentuated in individuals exposed to childhood maltreatment. However, gene*environment interactions are likely not a major contributor to the excess CVD burden experienced by childhood maltreatment victims.Competing Interest StatementThe authors have declared no competing interest.Funding StatementHU is funded by a PhD studentship from the British Heart Foundation (FS/17/60/33474). HU, ALGS, AF, LDH and ARC all work in a unit that receives core funding from the UK Medical Research Council and University of Bristol (MC_UU_00011/1, MC_UU_00011/4 and MC_UU_00011/6). ARC is additionally supported by the University of Bristol British Heart Foundation Accelerator Award (AA/18/7/34219). ALGS is supported by the study of Dynamic longitudinal exposome trajectories in cardiovascular and metabolic non-communicable diseases (H2020-SC1-2019-Single-Stage-RTD, project ID 874739). AF is supported by the National Institute for Health Research (NIHR) Biomedical Research Centre based at University Hospitals Bristol NHS Foundation and the University of Bristol. LDH is funded by a Career Development Award from the UK Medical Research Council (MR/M020894/1).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:UK Biobank has approval from the North West Multi-centre Research Ethics Committee (MREC) as a Research Tissue Bank (RTB) approval. All analyses were performed under approved UK Biobank project 19278.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript and in supplementary file. The code used in this analysis is available at github.com/helenaurquijo/gxe_cvd_maltreatment.AFAtrial fibrillationBMIBody mass indexCHDCoronary heart diseaseCVDCardiovascular diseaseGWASGenome-wide association studiesLDL-CLow-density lipoprotein cholesterolPCPrincipal componentsPGSPolygenic scoreRCTRandomised control trialsSBPSystolic blood pressureSEPSocioeconomic positionSNPSingle nucleotide polymorphismT2DMType-2 diabetes mellitus